Identification of cellular and molecular factors determining the response of cancer cells to six ergot alkaloids. (Q38945474)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342140%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

title

Identification of cellular and molecular factors determining the response of cancer cells to six ergot alkaloids (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342140%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342140%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342140%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Marco Mrusek

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342140%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Ean-Jeong Seo

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342140%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Michael Simon

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342140%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

publication date

25 October 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342140%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

21 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342140%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342140%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342140%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

page(s)

32-44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25342140%20AND%20SRC:MED&resulttype=core&format=json

Natural occurrence of mycotoxins in cereals

21 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

Natural products and derivatives affecting neurotransmission relevant to Alzheimer's and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

Orally inhaled dihydroergotamine: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

Which uterotonic is better to prevent the postpartum hemorrhage? Latest news in terms of clinical efficacy, side effects, and contraindications: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

Post-genome research on the biosynthesis of ergot alkaloids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

A gene expression database for the molecular pharmacology of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

Integrating global gene expression and radiation survival parameters across the 60 cell lines of the National Cancer Institute Anticancer Drug Screen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

Apoptosis and resistance to daunorubicin in human leukemic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

Cytotoxic activity of secondary metabolites derived from Artemisia annua L. towards cancer cells in comparison to its designated active constituent artemisinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

Protein expression profiles indicative for drug resistance of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

Reduced growth rate accompanied by aberrant epidermal growth factor signaling in drug resistant human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

Prediction of broad spectrum resistance of tumors towards anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

The role of p53 in chemosensitivity and radiosensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

The ras oncogenes increase the intrinsic resistance of NIH 3T3 cells to ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

mRNA expression profiles for the response of human tumor cell lines to the antimalarial drugs artesunate, arteether, and artemether.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

Pharmacogenomic determination of genes associated with sensitivity or resistance of tumor cells to curcumin and curcumin derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

Integration of Different "-omics" Technologies Identifies Inhibition of the IGF1R-Akt-mTOR Signaling Cascade Involved in the Cytotoxic Effect of Shikonin against Leukemia Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

The human ATP-binding cassette transporter genes: from the bench to the bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

Interaction of cytochrome P450 3A inhibitors with P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

Bromocriptine modulates P-glycoprotein function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

The role of mutant p53 in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

One, two, three--p53, p63, p73 and chemosensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

Cytotoxicity and accumulation of ergot alkaloids in human primary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

Cytotoxicity and fluorescence visualization of ergot alkaloids in human cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

COMPARE analysis of the toxicity of an iminoquinone derivative of the imidazo[5,4-f]benzimidazoles with NAD(P)H:quinone oxidoreductase 1 (NQO1) activity and computational docking of quinones as NQO1 substrates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

Synthesis, evaluation of anticancer activity and COMPARE analysis of N-bis(trifluoromethyl)alkyl-N'-substituted ureas with pharmacophoric moieties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

The use of DNA microarrays to investigate the pharmacogenomics of drug response in living systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

RedundancyMiner: De-replication of redundant GO categories in microarray and proteomics analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

Gene expression profile identifies tyrosine kinase c-Met as a targetable mediator of antiangiogenic therapy resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

CellMiner: a web-based suite of genomic and pharmacologic tools to explore transcript and drug patterns in the NCI-60 cell line set.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

Signal transduction pathways of the epidermal growth factor receptor in colorectal cancer and their inhibition by small molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

Acting locally and globally: Myc's ever-expanding roles on chromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

Cisplatin resistance and transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

The chemistry of peptidyltransferase center-targeted antibiotics: enzymatic resistance and approaches to countering resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

Proteomic analysis of multidrug-resistance mechanisms in adriamycin-resistant variants of DLKP, a squamous lung cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

Ergovaline binding and activation of D2 dopamine receptors in GH4ZR7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

Naturally occurring clavines: antagonism/partial agonism at 5-HT2A receptors and antagonism at alpha 1-adrenoceptors in blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-014-0168-4

Clavine alkaloids and derivatives as mutagens detected in the Ames test

21 January 2018

1 reference

12 December 2020

Ergotism: a change of persepective

1 reference

12 December 2020

Chemotherapy-induced resistance by ATP-binding cassette transporter genes.

1 reference

12 December 2020

Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay

1 reference

12 December 2020

Clavines. New antibiotics with cytostatic activity

1 reference

12 December 2020

Antibiotics that affect the ribosome.

1 reference

12 December 2020

Pharmacogenomics of a traditional Japanese herbal medicine (Kampo) for cancer therapy.

1 reference

12 December 2020

Role of oncogenes in resistance and killing by cancer therapeutic agents.

1 reference

12 December 2020

Clavines as antitumor agents, 3: Cytostatic activity and structure/activity relationships of 1-alkyl agroclavines and 6-alkyl 6-noragroclavines

1 reference

12 December 2020

Increased resistance to cis-diamminedichloroplatinum(II) in NIH 3T3 cells transformed by ras oncogenes

1 reference

12 December 2020

Mutagenicity experiments on agroclavines, new natural antineoplastic compounds

1 reference

12 December 2020

Clavines as antitumor agents; 2. Natural 8-hydroxymethyl-ergoline type clavines and their derivatives

1 reference

12 December 2020